Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.30 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.30 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.30 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.30 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Captamine SCHEMBL258800 | 0.78 | — | — | |
| Captamine SCHEMBL10386744 | 0.75 | — | — | |
| Captamine SCHEMBL126014 | 0.75 | — | — | |
| Captamine SCHEMBL8411585 | 0.75 | — | — | |
| SCHEMBL2462100 | 0.75 | — | — | |
| Captamine SCHEMBL11869601 | 0.75 | TDP1 (0.92) | TDP1ALDH1A1TSHRCA12CA2 | |
| Captamine SCHEMBL9709132 | 0.75 | — | — | |
| Captamine SCHEMBL2244968 | 0.72 | — | — | |
| SCHEMBL11223201 | 0.72 | TDP1 (0.60) | TDP1ALDH1A1TSHRCA12CA2 | |
| Captamine SCHEMBL28091581 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100209373-A1 | DITHIOLS AND USE THEREOF FOR STRENGTHENING THE HAIR | L'OREAL S.A. (FR) | 2010-08-19 | — | — | US | disclosed |
| US-20050019290-A1 | Dithiols and use thereof for strengthening the hair | L'OREAL S.A. (FR) | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100209373-A1 | DITHIOLS AND USE THEREOF FOR STRENGTHENING THE HAIR | KRT18, DSG1, DSP | TDP1 2663/4885ALDH1A1 2186/4885TSHR 2948/4885 |
| US-20050019290-A1 | Dithiols and use thereof for strengthening the hair | KRT18, DSG1, DSP | TDP1 2663/4885ALDH1A1 2186/4885TSHR 2948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.